Bachem Holding AGBCHMF 91 Pretax Margin % is 26.23% as of Dec. 2025, which is 23% above its 10-year median of 21.30. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $98.14 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, Bachem Holding AG ranks better than 87.75% on this metric.
The historical rank and industry rank for Bachem Holding AG's Pretax Margin % or its related term are showing as below:
BCHMF'
s Pretax Margin % Range Over the Past 10 Years
Min: 18.49 Med: 21.3 Max: 26.11
Current: 22.5
BCHMF's Pretax Margin % is ranked better than 87.75% of 947
companies
in the Biotechnology industry
Industry Median: -90.63
vs BCHMF: 22.50
Bachem Holding AG (OTCPK:BCHMF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Bachem Holding AG Pretax Margin % Related Terms
Bachem Holding AG Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Bachem Holding AG's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BCHMF vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Bachem Holding AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bachem Holding AG Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Bachem Holding AG's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bachem Holding AG (BCHMF) has a Pretax Margin % of 26.23% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bachem Holding AG and its competitors. This is 23% above median its historical median of 21.30. Over the past decade, Bachem Holding AG's Pretax Margin % has ranged from 18.49 to 26.11. According to the industry distribution chart, Bachem Holding AG ranks #116 out of 947 companies in the Biotechnology industry, placing it in the top 12.2%.
Is Bachem Holding AG's Pretax Margin % too high?
Bachem Holding AG's current Pretax Margin % of 26.23% is 23% above median its 10-year median of 21.30. Over the past 10 years, this metric has ranged from a low of 18.49 to a high of 26.11. Based on the distribution chart, Bachem Holding AG ranks #116 out of 947 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #116 out of 947 companies for Pretax Margin %. This places Bachem Holding AG in the top 12% of its industry — outperforming the majority of peers. Historically, Bachem Holding AG's own Pretax Margin % has ranged from 18.49 to 26.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bachem Holding AG and its competitors. Bachem Holding AG's current Pretax Margin % is 26.23%, which is 23% above median its own 10-year median of 21.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $98.14, compared to a current price of $87.34 — trading 11% below its estimated fair value. The current Pretax Margin % is 26.23%, which is 23% above median its 10-year median of 21.30. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Pretax Margin % is 26.23% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bachem Holding AG (BCHMF) Overvalued in 2026?
Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued.
The current stock price of $87.34 is trading 11% below its estimated GF Value™ of $98.14.
GuruFocus considers Bachem Holding AG to be Modestly Undervalued.
Key valuation signals for BCHMF:
Pretax Margin %: 26.23% (23% above median its 10-year median of 21.30)
GF Value™: $98.14 vs. price of $87.34 (11% below fair value)
No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score
Get the complete analysis for BCHMF
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCHMF has been successfully added to your 
